Baraclude

Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007

... (total revenue) 260 222 17 % 162 144 13 % 15 % baraclude 99 36 175 % 29 18 61 % 59 % Oncology ... (total revenue) 956 791 21 % 604 495 22 % 20 % baraclude 275 83 ** 88 50 76 % 77 % Oncology ...

Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels

...ient with Genotypic Resistance to baraclude - BOSTON, Nov. 2 /PRNewswire-FirstCall/ -- Brist...atients in this cohort were initially treated with baraclude 0.5 mg in study ETV-022 and continued treatment with baraclude 1 mg by enrolling in study ETV- 901 with a less th...

Hepatitis Day of Reckoning for a Happening Virus

... in India 'With the approval and launch of baraclude in India, Bristol-Myers Squibb will now be able to...neral of India has recently given the go-ahead for baraclude (entecavir) to treat chronic HEPATITIS B. baraclude is an oral antiviral therapy which will arrest the...

New Treatment for Chronic Hepatitis B

...he Food and Drug Administration (USA) had approved baraclude (entecavir) tablets and oral solution for treating... hepatitis B in adults.// The new medication baraclude slows down the progress of the disease by interfer...tion of liver fibrosis. More patients treated with baraclude showed much improvement in comparison to lamivudin...

Baraclude in Medical Technology

BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients

...tive patients, comparing the antiviral activity of baraclude and adefovir. All patients in this study had a hig... viral load from baseline in patients treated with baraclude was -7.82 log(10) copies/mL and was -5.96 log(10) ...to 10^5 copies/mL. -- 97 percent (n=28/29) of baraclude patients achieved ALT normalization (ALT of le...

BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients

...sposes Patients to Higher Rates of baraclude Resistance - PRINCETON, N.J., March 24 /PRNewswi...g mutations in the virus that confer resistance to baraclude (also called genotypic resistance) was 1.2 percent.... In lamivudine-refractory patients who received baraclude after treatment with lamivudine failed, the cumula...

Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

... "This study showed that when treated again with baraclude for 48 weeks, patients achieved responses similar ... ETV-901. -- ETV-027 compared 0.5 mg of baraclude vs. 100 mg of lamivudine in nucleoside-naive chron...TV-901 initially received a combination of 1 mg of baraclude plus 100 mg of lamivudine, and were subsequently s...

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients

...om study ETV-079, which showed that treatment with baraclude (entecavir) demonstrated greater viral load reduct... Study ETV-079 evaluated the antiviral activity of baraclude and adefovir, and enrolled patients who had a high...l load at 48 weeks. "The study results show that baraclude produced greater viral load reductions than adefov...

Baraclude in Medical Dictionary

B virus

...itis B virus causes hepatitis B in humans. ... Hepatitis B Virus . Statistics. Transmission. Symptoms. Acute vs. Chronic ... Learn why baraclude is an effective chronic hepatitis B treatment option. ... Your viral levels tell how much hepatitis B virus is in your blood. ... ...

Baraclude in Biological News

BARACLUDE data show low resistance over 5 years in nucleoside-naive hepatitis B patients

... (PRINCETON, NJ, March 24, 2008) New baraclude (entecavir) data presented today demonstrated a co...g mutations in the virus that confer resistance to baraclude (also called genotypic resistance) was 1.2 percent.... In lamivudine-refractory patients who received baraclude after treatment with lamivudine failed, the cumula...

FDA Approves New Treatment for Chronic Hepatitis B

...rug Administration (FDA) announced the approval of baraclude (entecavir) tablets and oral solution for the trea...ans are chronically infected with the HBV virus. baraclude slows the progression of chronic hepatitis B by in...h viral reproduction. FDA based its approval of baraclude on the results of three studies in which...

Baraclude in Biological Technology

Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company

... 297 263 13% 160 143 12% 12% Sustiva Franchise (total revenue) 273 226 21% 175 144 22% 15% baraclude 108 45 140% 29 17 71% 59% Oncology Erbitux 187 160 17% 185 158 17% N/A ...